National implementation of a race-neutral eGFR equation contributed to more modifications and higher kidney transplantation rates for Black candidates, according to study data published in the Journal ...

Initial results of a Phase 1 / 2 open label study of AT-02, the company’s lead pan-amyloid removal therapeutic candidate, in patients with AL amyloidosis will be presented at ASH.The presentation ...

Genmab will acquire Merus in a deal worth almost $8 billion for access to an EGFR × LGR5 bispecific called petosemtamab. The antibody is currently in two phase III trials in patients with head and ...

A team has devised a more accurate way of measuring an indicator of kidney function known as glomerular filtration rate (GFR) by taking aging into account. Annual health checkups regularly include ...

Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) ("Actinium" or the "Company"), a leader in the development of differentiated targeted radiotherapies, announced today that new preclinical data for ...

Editorial Note: We earn a commission from partner links on Forbes Advisor. Commissions do not affect our editors' opinions or evaluations. Disclaimer: Calculator results and default inputs are ...

Aumolertinib and osimertinib showed similar efficacy and safety in treating EGFR-mutant NSCLC, with no significant differences in progression-free survival or overall survival. The study involved 202 ...

Democratic nominee Zohran Mamdani is giving New Yorkers a chance to see how much cash they would save under his administration -- if he's able to make good on his campaign promises. Mamdani has found ...

After a median follow-up of 18.9 months, the median PFS was 8.3 months in the sac-TMT group and 4.3 months in the chemotherapy group (hazard ratio (HR), 0.49; 95% confidence interval (CI), 0.39 to ...

AI-driven nanomedicine advances enable personalized breast cancer treatments, combining precision, biomimetic nanocarriers, ...